Insulin-mimetics as therapeutic adjuncts for bone regeneration
US9999636B2 · kind B2 · utility
0Cited by
12References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2016 |
| Grant date | Jun 19, 2018 |
| Priority date | — |
| Expiry date | Jan 29, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of promoting bone healing or regeneration by locally administering insulin mimetic agents to patients in need thereof and new uses of insulin-mimetic compounds for accelerating bone-healing processes are disclosed. Bone injury treatment and void filler devices, products and kit suitable for local administration of insulin-mimetic, agents or compositions thereof to patients in need of such treatment are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.